Lancet (London, England) Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials..  404:949-961. 2024
• Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials..  403:1635-1648. 2024
• Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial..  401:281-293. 2022
• The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels..  400:1619-1654. 2022
• The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019..  400:563-591. 2022
• Mapping the complex systems that connects the urban environment to cognitive decline in adults aged 50 years and older: a group model building study..  -. 2022
• Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study..  398:1894-1904. 2021
• The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future..  398:1619-1662. 2021
• Fatal police violence by race and state in the USA, 1980-2019: a network meta-regression..  398:1239-1255. 2021
• Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050..  398:1317-1343. 2021
• Global and national high blood pressure burden and control..  398:932-933. 2021
• Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1..  398:503-521. 2021
• Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019..  397:2337-2360. 2021
• Hearing loss prevalence and years lived with disability, 1990-2019: findings from the Global Burden of Disease Study 2019..  397:996-1009. 2021
• Alzheimer's disease..  397:1577-1590. 2021
• The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises..  397:129-170. 2020
• Five insights from the Global Burden of Disease Study 2019..  396:1135-1159. 2020
• Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019..  396:1204-1222. 2020
• Further clinical interpretation and implications of KEYNOTE-048 findings..  396:378-379. 2020
• Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study..  395:1907-1918. 2020
• Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial..  395:1195-1207. 2020
• Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019..  396:1223-1249. 2020
• The challenges of using the Hospital Frailty Risk Score..  392:-. 2019
• The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate..  394:1836-1878. 2019
• Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial..  394:1169-1180. 2019
• Perioperative covert stroke in patients undergoing non-cardiac surgery (NeuroVISION): a prospective cohort study..  394:1022-1029. 2019
• Biodegradable-polymer stents versus durable-polymer stents..  393:1932-1933. 2019
• Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial..  393:1937-1947. 2019
• Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial..  393:1807-1818. 2019
• The 2018 report of the Lancet Countdown on health and climate change: shaping the health of nations for centuries to come..  392:2479-2514. 2018
• Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1859-1922. 2018
• Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..  392:1789-1858. 2018
• Quantifying Immunoscore performance..  392:-. 2018
• Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016..  391:2236-2271. 2018
• Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple?.  391:-. 2018
• The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health..  391:581-630. 2017
• What can Japan learn from tobacco control in the UK?.  390:933-934. 2017
• Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial..  390:267-275. 2017
• The Lancet Countdown: tracking progress on health and climate change..  389:1151-1164. 2016
• City planning and population health: a global challenge..  388:2912-2924. 2016
• Readmission destination and risk of mortality after major surgery: an observational cohort study..  386:884-95. 2015
• ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data..  385:441-51. 2014
• Delirium in elderly people--authors'reply..  383:-. 2014
• Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis..  383:1059-66. 2013
• Delirium in elderly people..  383:911-22. 2013
• Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial..  383:127-37. 2013
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis..  380:1662-73. 2012
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis..  380:1649-61. 2012
• Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data..  379:2053-62. 2012
• Treatment intensity at end of life--time to act on the evidence..  378:1364-5. 2011
• Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay..  377:487-93. 2011
• Celiprolol therapy for vascular Ehlers-Danlos syndrome..  376:1443-4. 2010
• Common genetic determinants of vitamin D insufficiency: a genome-wide association study..  376:180-8. 2010
• Diagnoses and factors associated with medical evacuation and return to duty for service members participating in Operation Iraqi Freedom or Operation Enduring Freedom: a prospective cohort study..  375:301-9. 2010
• Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis..  375:2073-81. 2010
• Racial disparities in clinical trial enrolment..  372:1713-4. 2008
• Central nervous system injury associated with cardiac surgery..  368:694-703. 2006
• Preconditioning-mediated neuroprotection through erythropoietin?.  359:96-7. 2002
• Prevention of dementia: Syst-Eur trial..  353:235; author reply 236-7. 1999
• Betacarotene and sunscreen use..  354:-. 1999
• How should clinical care of the aged differ?.  350:1157-8. 1997
• Use of tube feeding to prevent aspiration pneumonia..  348:1421-4. 1996
• Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease..  348:429-32. 1996
• Urinary incontinence..  346:94-9. 1995
• Effect of grapefruit juice on blood cyclosporin concentration..  345:955-6. 1995
• Global and national high blood pressure burden and control 2021
• Developing an infant feeding core outcome set for childhood obesity prevention 2018
• Health-care professional and parental views and experiences of implementing infant feeding interventions: a qualitative evidence synthesis 2018
• The need for transparency of clinical evidence for medical devices in Europe 2018
• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials 2013
• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials 2013
• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials 2013
• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials 2013
• Subclinical thyroid disorders 2012
• The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials 2012
• Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials 2010
• Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials 2010
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials 2009
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials 2009
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials 2009
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials 2009
• Aspirin in the primary prevention of vascular disease – ATT secretariat's reply 2009
• Statins and diabetes - Authors' reply 2008
• Efficacy and safety of cholesterol-lowering treatment – Authors' reply 2006
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins 2005
• Global burden of hypertension: analysis of worldwide data 2005
• Global burden of hypertension: analysis of worldwide data 2005
• Global burden of hypertension: analysis of worldwide data 2005
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials 2000
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure 1993
• Medical research in war-torn Syria: medical students' perspective. 2018
• The US immigration ban: implications for medical education and the physician workforce. 2017
• Field hospitals in Syria. 2014

Identity

International Standard Serial Number (ISSN)

• 0140-6736
• 1474-547X